Disability-adjusted life year
The disability-adjusted life year (DALY) is a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability or early death. It was developed in the 1990s as a way of comparing the overall health and life expectancy of different countries.
The DALY is becoming increasingly common in the field of public health and health impact assessment (HIA). It "extends the concept of potential years of life lost due to premature death...to include equivalent years of 'healthy' life lost by virtue of being in states of poor health or disability." In so doing, mortality and morbidity are combined into a single, common metric.
The disability-adjusted life year extends the notion of life expectancy to include the disease or disability burden in populations. An earlier attempt to do this was the quality-adjusted life year (QALY) measure, which measured the cost of medical care during lifetime but did not include the cost of premature death.
Traditionally, health liabilities were expressed using one measure, the Years of Life Lost (YLL) due to dying early. A medical condition that did not result in dying younger than expected was not counted. The Years lost due to disability (YLD) component measures the burden of living with a disease or disability.
DALYs are calculated by taking the sum of these two components:
- DALY = YLL + YLD
The DALY relies on an acceptance that the most appropriate measure of the effects of chronic illness is time, both time lost due to premature death and time spent disabled by disease. One DALY, therefore, is equal to one year of healthy life lost.
How much a medical condition affects a person is called the disability weight (DW). This is determined by disease or disability and does not vary with age. Tables have been created of thousands of diseases and disabilities, ranging from Alzheimer's disease to loss of finger, with the disability weight meant to indicate the level of disability that result from the specific condition.
|Condition||DW 2004||DW 2010|
|Alzheimer's and other dementias||0.666||0.666|
|AIDS, not on ART||0.505||0.547|
|Burns 20%-60% of body||0.441||0.438|
|Moderate depression episode||0.350||0.406|
|Amputation of foot||0.300||0.021-0.1674|
|Amputation of finger||0.102||0.030|
|Low back pain||0.061||0.322-0.374|
Examples of the disability weight are shown on the right. Some of these are "short term" and the long-term weights may be different.
The most noticeable change between the 2004 and 2010 figures for disability weights above are for blindness as it was considered the weights are a measure of health rather than wellbeing (or welfare) and a blind person is not considered to be ill. "In the GBD terminology, the term disability is used broadly to refer to departures from optimal health in any of the important domains of health."
At the population level, the disease burden as measured by DALYs is calculated by adding YLL to YLD. YLL uses the life expectancy at the time of death. YLD is determined by the number of years disabled weighted by level of disability caused by a disability or disease using the formula:
- YLD = I x DW x L
In this formula I = number of incident cases in the population, DW = disability weight of specific condition, and L = average duration of the case until remission or death (years). There is also a prevalence (as opposed to incidence) based calculation for YLD. Premature death is calculated by YLL = N x L, where N = number of deaths due to condition, L = standard life expectancy at age of death (expectancy - age at death).
A crucial distinction among DALY studies has been the use of "age-weighting", in which the value of each year of life depends on age. There are two components to this differential accounting of time: age-weighting and time-discounting. Age-weighting is based on the theory of human capital. Commonly, years lived as a young adult are valued more highly than years spent as a young child or older adult, as these are years of peak productivity. Age-weighting receives considerable criticism for valuing young adults at the expense of children and the old. Some criticize, while others rationalize, this as reflecting society's interest in productivity and receiving a return on its investment in raising children. This age-weighting system means that somebody disabled at 30 years of age, for ten years, would be measured as having a higher loss of DALYs (a greater burden of disease), than somebody disabled by the same disease or injury at the age of 70 for ten years.
This age-weighting function is by no means a universal methodology in HALY studies, but is common when using DALYs. Cost-effectiveness studies using QALYs, for example, do not discount time at different ages differently. This age-weighting function applies only to the calculation of DALYs lost due to disability. Years lost to premature death are determined from the age at death and life expectancy.
 where is the age at which the year is lived and is the value assigned to it relative to an average value of 1.
In these studies future years were also discounted at a 3% rate to account for future health care losses. Time discounting, which is separate from the age-weighting function, describes preferences in time as used in economic models.
The effects of the interplay between life expectancy and years lost, discounting, and social weighting are complex, depending on the severity and duration of illness. For example, the parameters used in the GBD 1990 study generally give greater weight to deaths at any year prior to age 39 than afterward, with the death of a newborn weighted at 33 DALYs and the death of someone aged 5–20 weighted at approximately 36 DALYs.
As a result of numerous discussions, by 2010 the World Health Organization had abandoned the ideas of age weighting and time discounting. They had also substituted the idea of prevalence for incidence (when a condition started) because this is what surveys measure.
The methodology is not an economic measure. It measures how much healthy life is lost. It does not assign a monetary value to any person or condition, and it does not measure how much productive work or money is lost as a result of death and disease. However, HALYs, including DALYs and QALYs, are especially useful in guiding the allocation of health resources as they provide a common denominator, allowing for the expression of utility in terms of DALYs/dollar, or QALY/dollar. For example, in Gambia, provision of the pneumococcal conjugate vaccine costs $670 per DALY saved. This number can then be compared to other treatments for other diseases, to determine whether investing resources in preventing or treating a different disease would be more efficient in terms of overall health.
Cancer (25.1/1,000), cardiovascular (23.8/1,000), mental problems (17.6/1,000), neurological (15.7/1,000), chronic respiratory (9.4/1,000) and diabetes (7.2/1,000) are the main causes of good years of expected life lost to disease or premature death. Despite this, Australia has one of the longest life expectancies in the world.
These illustrate the problematic diseases and outbreaks occurring in 2013 in Zimbabwe, shown to be most highly impacted by health disability were typhoid, anthrax, malaria, common diarrhea, and dysentery.
Posttraumatic stress disorder (PTSD) DALY estimates from 2004 for the world's 25 most populous countries give Asian/Pacific countries and the United States as the places where PTSD impact is most concentrated (as shown here).
Noise-Induced Hearing Loss
The disability-adjusted life years attributable to hearing impairment for noise-exposed U.S. workers across all industries was calculated to be 2.53 healthy years were lost annually per 1,000 noise-exposed workers. Workers in the mining and construction sectors lost 3.45 and 3.09 healthy years per 1,000 workers, respectively. Overall, 66% of the sample worked in the manufacturing sector and represented 70% of healthy years lost by all workers.
History and usage
Originally developed by Harvard University for the World Bank in 1990, the World Health Organization subsequently adopted the method in 1996 as part of the Ad hoc Committee on Health Research "Investing in Health Research & Development" report. The DALY was first conceptualized by Murray and Lopez in work carried out with the World Health Organization and the World Bank known as the global burden of disease study, which was published in 1990. It is now a key measure employed by the United Nations World Health Organization in such publications as its Global Burden of Disease.
Although some have criticized DALYs as essentially an economic measure of human productive capacity for the affected individual,[irrelevant citation] this is not so. DALYs do have an age-weighting function that has been rationalized based on the economic productivity of persons at that age, but health-related quality of life measures are used to determine the disability weights, which range from 0 to 1 (no disability to 100% disabled) for all disease. These weights are based not on a person's ability to work, but rather on the effects of the disability on the person's life in general. This is why mental illness is one of the leading diseases as measured by global burden of disease studies, with depression accounting for 51.84 million DALYs. Perinatal conditions, which affect infants with a very low age-weight function, are the leading cause of lost DALYs at 90.48 million. Measles is fifteenth at 23.11 million.
- Bhutan GNH Index
- Broad measures of economic progress
- Disease burden
- Full cost accounting
- Green national product
- Green gross domestic product (Green GDP)
- Gender-related Development Index
- Genuine Progress Indicator (GPI)
- Global Peace Index
- Gross National Happiness
- Gross National Well-being (GNW)
- Happiness economics
- Happy Planet Index (HPI)
- Human Development Index (HDI)
- ISEW (Index of sustainable economic welfare)
- Progress (history)
- Progressive utilization theory
- Legatum Prosperity Index
- Leisure satisfaction
- Living planet index
- Law of Social Cycle
- Millennium Development Goals (MDGs)
- Money-rich, time-poor
- Subjective life satisfaction
- Where-to-be-born Index
- World Values Survey (WVS)
- World Happiness Report
- Quality-adjusted life year (QALY)
- Healthy Life Years
- Happiness economics
- Seven Ages of Man
- "WHO Disease and injury country estimates". World Health Organization. 2009. Retrieved Nov 11, 2009.
- "Death and DALY estimates for 2004 by cause for WHO Member States: Persons, all ages" (xls). World Health Organization. 2002. Retrieved 2009-11-12.
- Havelaar, Arie (August 2007). "Methodological choices for calculating the disease burden and cost-of-illness of foodborne zoonoses in European countries" (PDF). Med-Vet-Net. Archived from the original (PDF) on 21 Jan 2009. Retrieved 2008-04-05.
- "GLOBAL BURDEN OF DISEASE 2004 UPDATE: DISABILITY WEIGHTS FOR DISEASES AND CONDITIONS" (PDF). World Health Organization. 2004. Retrieved Jul 25, 2016.
- WHO 2013.
- WHO 2013, p. 15.
- "Metrics: Disability-Adjusted Life Year (DALY)". Retrieved 29 October 2014.
- Menken M, Munsat TL, Toole JF (March 2000). "The global burden of disease study: implications for neurology". Arch. Neurol. 57 (3): 418–20. doi:10.1001/archneur.57.3.418. PMID 10714674.
- Murray, Christopher J (1994). "Quantifying the burden of disease: the technical basis for disability-adjusted life years". Bulletin of the World Health Organization. 72: 429–45. PMC . PMID 8062401.
- Gold, MR; Stevenson, D; Fryback, DG (2002). "HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health". Annual Review of Public Health. 23: 115–34. doi:10.1146/annurev.publhealth.23.100901.140513. PMID 11910057.
- "Disability weights, discounting and age weighting of DALYs". WHO.
- Prüss-Üstün, A.; Mathers, C.; Corvalán, C.; Woodward, A. (2003). "3 The Global Burden of Disease concept" (PDF). Introduction and methods: Assessing the environmental burden of disease at national and local levels. Environmental burden of disease. 1. World Health Organization. ISBN 92 4 154620 4.
- Kramer, Alexander; Hossain, Mobarak; Kraas,, Frauke (2011). Health in megacities and urban areas. Heidelberg: Physica-Verlag. ISBN 978-3-7908-2732-3.
- Mathers CD, Ezzati M, Lopez AD (2007). "Measuring the burden of neglected tropical diseases: the global burden of disease framework". PLoS Negl Trop Dis. 1 (2): e114. doi:10.1371/journal.pntd.0000114. PMC . PMID 18060077.
- "WHO methods and data sources for global burden of disease estimates 2000-2011" (PDF). World Health Organization. 2013. Retrieved Jul 27, 2016.
- Kim, SY; Lee, G; Goldie, SJ (Sep 3, 2010). "Economic evaluation of pneumococcal conjugate vaccination in The Gambia.". BMC infectious diseases. 10: 260. doi:10.1186/1471-2334-10-260. PMID 20815900.
- Chant, Kerry (November 2008). "The Health of the People of New South Wales (summary report)" (PDF). Chief Health Officer, Government of New South Wales. Retrieved 2009-01-17.
- Zimbabwe, Ministry of Health and Child Welfare (December 2013). "Zimbabwe Weekly Epidemiological Bulletin" (PDF). World Health Organization, Government of Zimbabwe. Retrieved 2014-02-24.
- Masterson EA, Bushnell PT, Themann CL, Morata, TC (2016). "Hearing Impairment Among Noise-Exposed Workers — United States, 2003–2012.". MMWR Morb Mortal Wkly Rep 2016;65:389–394. Retrieved 05/04/2016. Check date values in:
- Global Burden of Disease
- Thacker SB, Stroup DF, Carande-Kulis V, Marks JS, Roy K, Gerberding JL (2006). "Measuring the public's health". Public Health Rep. 121 (1): 14–22. PMC . PMID 16416694.
- Kramer, Alexander , Md. Mobarak Hossain Khan, Frauke Kraas, (2011). Health in megacities and urban areas. Heidelberg: Physica-Verlag. ISBN 978-3-7908-2732-3.
- "Quantifying the burden of disease: the technical basis for disability-adjusted life years.". Bull World Health Organ. 72: 429–45. 1994. PMC . PMID 8062401.